BIOSA: Beyond the Breakthrough: Innovation, Regulation, and Patient Impact

Beyond the Breakthrough: Innovation, Regulation, and Patient Impact

BIOSA is bringing together industry experts for an engaging panel discussion designed to help health technology companies, from early-stage innovators to established, revenue-generating businesses, navigate the complex journey from innovation to patient impact. Attendees will gain practical insights into regulatory strategy, commercialization readiness, investor expectations, patient access, and the resources available through Arizona’s growing life sciences ecosystem to accelerate success.

Featured Panelists

Ed Kim, MD, MBA
Senior Vice President, City of Hope
Director, Clinical Trials Office, City of Hope National Medical Center

Scott Johnson, MBA
Chief Executive Officer, OrangeTree MedTech
Past President, DeviceAlliance

Tina Higgins, PhD, RAC
Principal, Higgins McNamara Consulting

Huong Huynh, PhD
Director of Regulatory Science, Critical Path Institute

Why Attend?

Whether you are developing, launching, or scaling a medical device, diagnostic, digital health solution, or therapeutic technology, don’t miss this opportunity to hear directly from leaders in regulatory science, clinical research, medical technology, and commercialization.